I don't know, does it? I'm not paying for it, that is your stroke hospital responsibility.
Does fluoxetine improve recovery after stroke?
BMJ
2019;
364
doi: https://doi.org/10.1136/bmj.l1029
(Published 25 March 2019)
Cite this as: BMJ 2019;364:l1029
- Rob Cook, clinical director1,
- Vaughan Thomas, clinical adviser2,
- Rosie Martin, clinical specialist1
- on behalf of NIHR Dissemination Centre
- Correspondence to R Cook rob.cook@bazian.com
The study
FOCUS
Trial Collaboration. Effects of fluoxetine on functional outcomes after
acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled
trial. Lancet 2019;393:256-74.
The study was funded by the UK Stroke Association and the NIHR Health Technology Assessment Programme project number 13/04/30.
To read the full NIHR Signal, go to: https://discover.dc.nihr.ac.uk/content/signal-000729/a-commonly-used-antidepressant-doesnt-improve-recovery-after-stroke
Footnotes
- Competing interestsThe BMJ has judged that there are no disqualifying financial ties to commercial companies. The authors declare the following other interests: none.
- Further details of the BMJ policy on financial interests is here: https://www.bmj.com/about-bmj/resources-authors/forms-policies-and-checklists/declaration-competing-interests
- Contributors Anna Sayburn.
- All authors contributed to the development and review of this summary, as part of the wider NIHR Signals editorial team (https://www.bmj.com/NIHR-signals). RC is guarantor.
- Disclaimer NIHR Signals are owned by the Department of Health and Social Care and are made available to the BMJ under licence. NIHR Signals report and comment on health and social care research but do not offer any endorsement of the research. The NIHR assumes no responsibility or liability arising from any error or omission or from the use of any information contained in NIHR Signals.
- Permission to reuse these articles should be directed to disseminationcentre@nihr.ac.uk.
No comments:
Post a Comment